Indoleamine 2,3-dioxygenase 1 (IDO1) activity correlates with immune system abnormalities in multiple myeloma

Indoleamine 2,3-dioxygenase 1 (IDO1) activity correlates with immune system abnormalities in multiple myeloma

<p>Abstract</p> <p>Background</p> <p>Multiple myeloma (MM) is a plasma cell malignancy with a multifaceted immune dysfunction. Indoleamine 2,3-dioxygenase 1 (IDO1) degrades tryptophan into kynurenine (KYN), which inhibits effector T cells and promote regulatory T-cell (...

Full description

Bibliographic Details
Main Authors:	Bonanno Giuseppina, Mariotti Andrea, Procoli Annabella, Folgiero Valentina, Natale Daniela, De Rosa Luca, Majolino Ignazio, Novarese Linda, Rocci Alberto, Gambella Manuela, Ciciarello Marilena, Scambia Giovanni, Palumbo Antonio, Locatelli Franco, De Cristofaro Raimondo, Rutella Sergio
Format:	Article
Language:	English
Published:	BMC 2012-12-01
Series:	Journal of Translational Medicine
Online Access:	http://www.translational-medicine.com/content/10/1/247

Similar Items

Cyclooxygenase-2 (COX-2) Inhibition Constrains Indoleamine 2,3-Dioxygenase 1 (IDO1) Activity in Acute Myeloid Leukaemia Cells
by: Sergio Rutella, et al.
Published: (2013-08-01)

Manipulation of indoleamine 2,3-dioxygenase (IDO) for clinical transplantation: promises and challenges.
by: Quan, J, et al.
Published: (2008)

Manipulation of indoleamine 2,3-dioxygenase (IDO) for clinical transplantation: promises and challenges
by: Quan, J, et al.
Published: (2008)

TRYPTOPHAN AND INDOLEAMINE-2,3-DIOXYGENASE (IDO) IN PATHOGENESIS OF IMMUNOSUPPRESSIVE CLINICAL CONDITIONS
by: V. A. Kozlov, et al.
Published: (2017-07-01)

Indoleamine 2,3-dioxygenase (IDO): Only an enzyme or a checkpoint controller?
by: Cemil Bilir, M.D., et al.
Published: (2017-07-01)

Effects of pegylated G-CSF on immune cell number and function in patients with gynecological malignancies
by: De Cristofaro Raimondo, et al.
Published: (2010-11-01)

Single-nucleotide polymorphisms and activities of indoleamine 2,3-dioxygenase isoforms, IDO1 and IDO2, in tuberculosis patients
by: Tingming Cao, et al.
Published: (2022-01-01)

Tolerance induction by monoclonal CD3 antibodies is dependent on indoleamine 2,3 dioxygenase (IDO)
by: Kuhn, C, et al.
Published: (2012)

Indoleamine 2,3-Dioxygenase (IDO) Downregulates the Cell Surface Expression of the CD4 Molecule
by: Lingfei Wu, et al.
Published: (2012-08-01)

Activity of Indoleamine 2, 3 Dioxygenase (IDO) in Type 2 Diabetes Mellitus Patients in Pakistan
by: Syed Harris Hussain
Published: (2017-06-01)

Interleukin-21 induces the differentiation of human umbilical cord blood CD34<sup>-</sup>lineage<sup>- </sup>cells into pseudomature lytic NK cells
by: Scambia Giovanni, et al.
Published: (2009-08-01)

The role of indoleamine 2,3-dioxygenase (IDO) in the pathogenesis of non-alcoholic steatohepatitis (NASH) and atherosclerosis as comorbidities
by: Arora, A, et al.
Published: (2021)

Indoleamine 2,3-Dioxygenase 1 (IDO1) in Kidney Transplantation: A Guardian against Rejection
by: Krzysztof Wiśnicki, et al.
Published: (2023-12-01)

Indoleamine 2,3-Dioxygenase (IDO) Activity: A Perspective Biomarker for Laboratory Determination in Tumor Immunotherapy
by: Pengbo Yang, et al.
Published: (2023-07-01)

Structure-based optimization of type III indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors
by: Ute F. Röhrig, et al.
Published: (2022-12-01)

Activities of plasma indoleamine-2, 3-dioxygenase (IDO) enzyme in Nigerian patients with lung diseases: basis for tryptophan supplementation or IDO inhibitor use
by: Ganiyu Olatunbosun Arinola, et al.
Published: (2023-01-01)

Human Indoleamine 2,3-dioxygenase 1 (IDO1) Expressed in Plant Cells Induces Kynurenine Production
by: Michele Bellucci, et al.
Published: (2021-05-01)

Immunohistochemical Features of Indoleamine 2,3-Dioxygenase (IDO) in Various Types of Lymphoma: A Single Center Experience
by: Mee-seon Kim, et al.
Published: (2020-05-01)

Fatigue in Patients on Chronic Hemodialysis: The Role of Indoleamine 2,3-Dioxygenase (IDO) Activity, Interleukin-6, and Muscularity
by: Alessio Molfino, et al.
Published: (2023-02-01)

Indoleamine 2,3-dioxygenase 1 (ido1) is involved in the control of mouse caput epididymis immune environment.
by: Aicha Jrad-Lamine, et al.
Published: (2013-01-01)

Respiratory syncytial virus replication induces Indoleamine 2,3-dioxygenase (IDO) activation in human dendritic cells
by: Ajamian Farnam, et al.
Published: (2010-11-01)

Deletion of indoleamine 2,3 dioxygenase (Ido)1 but not Ido2 exacerbates disease symptoms of MOG35-55-induced experimental autoimmune encephalomyelitis
by: Lisa A. Wetzel, et al.
Published: (2020-08-01)

Increased Indoleamine 2,3-Dioxygenase 1 (IDO-1) Activity and Inflammatory Responses during Chikungunya Virus Infection
by: Thiara Manuele Alves de Souza, et al.
Published: (2022-04-01)

Progesterone decreased indoleamine 2,3-dioxygenase 1(IDO1) expression in early pregnancy chorionic villi and decidua
by: Minyan Yang, et al.
Published: (2021-04-01)

Discovery of Indoleamine 2,3-Dioxygenase 1 (IDO-1) Inhibitors Based on Ortho-Naphthaquinone-Containing Natural Product
by: Hongchuan Zhao, et al.
Published: (2019-03-01)

Interferon-γ regulates the proliferation and differentiation of mesenchymal stem cells via activation of indoleamine 2,3 dioxygenase (IDO).
by: Juliana Croitoru-Lamoury, et al.
Published: (2011-01-01)

Synthesis and Molecular Modeling Studies of N′-Hydroxyindazolecarboximidamides as Novel Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors
by: Dong-Ho Lee, et al.
Published: (2017-11-01)

Indoleamine 2,3-dioxygenase in endometriosis
by: Hui-Li Yang, et al.
Published: (2019-01-01)

Preferential expression of CD200 and Indoleamine 2, 3-dioxygenase-1 (IDO-1) in Acute Myeloid Leukemia Patients with Relapse
by: Ali Memarian, et al.
Published: (2015-12-01)

Contribution of indoleamine 2,3-dioxygenase in preeclampsia
by: Mona F.M El-Karn, et al.
Published: (2016-01-01)

Targeting Indoleamine Dioxygenase and Tryptophan Dioxygenase in Cancer Immunotherapy: Clinical Progress and Challenges
by: Peng X, et al.
Published: (2022-08-01)

Editorial: Targeting Indoleamine 2,3-dioxygenases and Tryptophan Dioxygenase for Cancer Immunotherapy
by: Lieve Brochez, et al.
Published: (2021-12-01)

Systemic treatment with CpG-B after sublethal rickettsial infection induces mouse death through indoleamine 2,3-dioxygenase (IDO).
by: Lijun Xin, et al.
Published: (2012-01-01)

Discovery of cyanopyridine scaffold as novel indoleamine-2,3-dioxygenase 1 (IDO1) inhibitors through virtual screening and preliminary hit optimisation
by: Xi Xu, et al.
Published: (2019-01-01)

May critical molecular cross-talk between indoleamine 2,3-dioxygenase (IDO) and arginase during human aging be targets for immunosenescence control?
by: Ismael Dale Cotrim Guerreiro da Silva, et al.
Published: (2021-08-01)

Rational design of indoleamine 2,3-dioxygenase inhibitors.
by: Röhrig, U, et al.
Published: (2010)

The Synergistic Local Immunosuppressive Effects of Neural Stem Cells Expressing Indoleamine 2,3-Dioxygenase (IDO) in an Experimental Autoimmune Encephalomyelitis (EAE) Animal Model.
by: Young Eun Lee, et al.
Published: (2015-01-01)

Phase Ia study of the indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor navoximod (GDC-0919) in patients with recurrent advanced solid tumors
by: Asha Nayak-Kapoor, et al.
Published: (2018-06-01)

Indoleamine 2, 3-dioxygenase (IDO) increases during renal fibrogenesis and its inhibition potentiates TGF-β 1-induced epithelial to mesenchymal transition
by: Luiz Henrique Gomes Matheus, et al.
Published: (2017-09-01)

Thymoglobulin, interferon-γ and interleukin-2 efficiently expand cytokine-induced killer (CIK) cells in clinical-grade cultures
by: Corallo Maria, et al.
Published: (2010-12-01)